Back
Rate this talk
Your peers have not rated this talk yet.
10-minute watch | Talk 6 of 7

ICML: Improving outcomes in R/R DLBCL: Learning from challenging cases

Case study 4: CAR T in the outpatient setting

Dr Olalekan Oluwole
SYMPOSIUM
ICML

Dr Olalekan Oluwole
Vanderbilt University Medical Center, Nashville, Tennessee, USA

Dr Olalekan Oluwole, Vanderbilt University Medical Center, Nashville, Tennessee, USA, uses a case study to illustrate the management of patients receiving CAR T-cell therapy in the outpatient setting

Read more

Talks in this series

Prof. Marie José Kersten, Prof. Christopher Fox, Dr Wendy Osborne, Dr Miguel-Angel Perales and Dr Olalekan Oluwole present at ICML (Improving outcomes in R_R DLBCL)
1-minute watch | Talk 1 of 7
ICML: Improving outcomes in R/R DLBCL: Learning from challenging cases
Series trailer
Prof. Marie José Kersten, Prof. Christopher Fox, Dr Wendy Osborne, Dr Miguel-Angel Perales and Dr Olalekan Oluwole present at ICML (Improving outcomes in R_R DLBCL)
1-minute watch
ICML: Improving outcomes in R/R DLBCL: Learning from challenging cases

Series trailer

Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
7-minute watch | Talk 2 of 7
Welcome, introduction and challenges in R/R DLBCL: Overview
Prof. Marie José Kersten
Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
7-minute watch

Welcome, introduction and challenges in R/R DLBCL: Overview

Prof. Marie José Kersten

Prof. Christopher Fox presents at ICML (Improving outcomes in R_R DLBCL)
11-minute watch | Talk 3 of 7
Case study 1: Hard to manage ICANS
Prof. Christopher Fox
Prof. Christopher Fox presents at ICML (Improving outcomes in R_R DLBCL)
11-minute watch

Case study 1: Hard to manage ICANS

Prof. Christopher Fox

Dr Wendy Osborne presents at ICML (Improving outcomes in R_R DLBCL)
5-minute watch | Talk 4 of 7
Case study 2: Managing bulky disease
Dr Wendy Osborne
Dr Wendy Osborne presents at ICML (Improving outcomes in R_R DLBCL)
5-minute watch

Case study 2: Managing bulky disease

Dr Wendy Osborne

Dr Miguel-Angel Perales presents at ICML (Improving outcomes in R_R DLBCL)
6-minute watch | Talk 5 of 7
Case study 3: Achieving a CR after bridging and the use of CAR T
Dr Miguel-Angel Perales
Dr Miguel-Angel Perales presents at ICML (Improving outcomes in R_R DLBCL)
6-minute watch

Case study 3: Achieving a CR after bridging and the use of CAR T

Dr Miguel-Angel Perales

Dr Olalekan Oluwole presents at ICML (Improving outcomes in R_R DLBCL)
10-minute watch | Talk 6 of 7
Case study 4: CAR T in the outpatient setting
Dr Olalekan Oluwole
Dr Olalekan Oluwole presents at ICML (Improving outcomes in R_R DLBCL)
10-minute watch

Case study 4: CAR T in the outpatient setting

Dr Olalekan Oluwole

Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
5-minute watch | Talk 7 of 7
Close
Prof. Marie José Kersten
Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
5-minute watch

Close

Prof. Marie José Kersten

Prof. Marie José Kersten, Prof. Christopher Fox, Dr Wendy Osborne, Dr Miguel-Angel Perales and Dr Olalekan Oluwole present at ICML (Improving outcomes in R_R DLBCL)
1-minute watch | Talk 1 of 7
ICML: Improving outcomes in R/R DLBCL: Learning from challenging cases
Series trailer
Prof. Marie José Kersten, Prof. Christopher Fox, Dr Wendy Osborne, Dr Miguel-Angel Perales and Dr Olalekan Oluwole present at ICML (Improving outcomes in R_R DLBCL)
1-minute watch
ICML: Improving outcomes in R/R DLBCL: Learning from challenging cases

Series trailer

Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
7-minute watch | Talk 2 of 7
Welcome, introduction and challenges in R/R DLBCL: Overview
Prof. Marie José Kersten
Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
7-minute watch

Welcome, introduction and challenges in R/R DLBCL: Overview

Prof. Marie José Kersten

Prof. Christopher Fox presents at ICML (Improving outcomes in R_R DLBCL)
11-minute watch | Talk 3 of 7
Case study 1: Hard to manage ICANS
Prof. Christopher Fox
Prof. Christopher Fox presents at ICML (Improving outcomes in R_R DLBCL)
11-minute watch

Case study 1: Hard to manage ICANS

Prof. Christopher Fox

Dr Wendy Osborne presents at ICML (Improving outcomes in R_R DLBCL)
5-minute watch | Talk 4 of 7
Case study 2: Managing bulky disease
Dr Wendy Osborne
Dr Wendy Osborne presents at ICML (Improving outcomes in R_R DLBCL)
5-minute watch

Case study 2: Managing bulky disease

Dr Wendy Osborne

Dr Miguel-Angel Perales presents at ICML (Improving outcomes in R_R DLBCL)
6-minute watch | Talk 5 of 7
Case study 3: Achieving a CR after bridging and the use of CAR T
Dr Miguel-Angel Perales
Dr Miguel-Angel Perales presents at ICML (Improving outcomes in R_R DLBCL)
6-minute watch

Case study 3: Achieving a CR after bridging and the use of CAR T

Dr Miguel-Angel Perales

Dr Olalekan Oluwole presents at ICML (Improving outcomes in R_R DLBCL)
10-minute watch | Talk 6 of 7
Case study 4: CAR T in the outpatient setting
Dr Olalekan Oluwole
Dr Olalekan Oluwole presents at ICML (Improving outcomes in R_R DLBCL)
10-minute watch

Case study 4: CAR T in the outpatient setting

Dr Olalekan Oluwole

Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
5-minute watch | Talk 7 of 7
Close
Prof. Marie José Kersten
Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
5-minute watch

Close

Prof. Marie José Kersten

Interested in this topic?

Find more like this

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In the United Kingdom, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.